Patent abuse delays market entry for lower-cost generic medicines and keeps drug prices out of reach for Americans. Policymakers must take action to stop patent abuse.
Quick Links:
Widespread adoption has saved the U.S. healthcare system $3.1 trillion. But this success story is in jeopardy.
Generics and biosimilars saved $445 billion in 2023, highlighting the importance of protecting competition under the Hatch-Waxman Act.
Desi’s journey from painful swelling to playing soccer again shows the power of accessible medicines.
Learn how a biosimilar medication helped Eileen stay focused on auditions, not Crohn’s disease.
Generic and biosimilar medicines make it easier and more affordable for patients to live healthier lives.
